[1]孙玉晨,杨生伟,王惠娟.HJURP在人脑胶质瘤中的表达及意义：基于CGGA数据库的生信分析[J].中国临床神经外科杂志,2024,29(12):724-728.[doi:10.13798/j.issn.1009-153X.2024.12.005]
　SUN Yu-chen,YANG Sheng-wei,WANG Hui-juan.Expression and significance of HJURP in human glioma: a bioinformatics analysis based on the CGGA database[J].,2024,29(12):724-728.[doi:10.13798/j.issn.1009-153X.2024.12.005]
点击复制

HJURP在人脑胶质瘤中的表达及意义：基于CGGA数据库的生信分析()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
29
期数:
2024年12期
页码:
724-728
栏目:
论著
出版日期:
2024-12-30

文章信息/Info

Title:
Expression and significance of HJURP in human glioma: a bioinformatics analysis based on the CGGA database
文章编号:
1009-153X（2024）12-0724-05
作者:
孙玉晨; 杨生伟; 王惠娟
050000石家庄，河北医科大学第二医院神经外科（孙玉晨），神经内科（王惠娟）；427000湖南，张家界市人民医院神经外科（杨生伟）
Author(s):
SUN Yu-chen1;  YANG Sheng-wei2;  WANG Hui-juan3
1. Department of Neurosurgery, The Second Hosipital of Hebei Medical University, Shijiazhuang 050000, China; 2. Department of Neurosurgery, Zhangjiajie People's Hospital, Zhangjiajie427000, China; 3. Department of Neurology, The Second Hosipital of Hebei Medical University, Shijiazhuang 050000, China
关键词:
脑胶质瘤; Holliday交叉识别蛋白（HJURP）; 临床特征; 病理特征; 预后
Keywords:
Glioma;  Holliday junction recognition protein;  Clinical characteristics;  Pathological characteristics;  Prognosis
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2024.12.005
文献标志码:
A
摘要:
目的 探讨Holliday交叉识别蛋白（HJURP）在人脑胶质瘤中的表达及其与临床、病理特征及预后的关系。方法 计算机检索中国脑胶质瘤基因组图谱（CGGA）数据库获取mRNAseq-325数据集中325例胶质瘤的转录组测序（RNA-seq）数据及临床资料，应用mRNAseq-693数据集中693例脑胶质瘤数据进行验证。利用R语言软件分析HJURP的表达和脑胶质瘤临床、病理特征的关系。使用Kaplan-Meier生存分析评估HJURP表达对人脑胶质瘤生存的影响。结果 胶质瘤HJURP的表达水平明显上调（P<0.05）；其表达水平与胶质瘤IDH基因型、1p19q共缺失状态、WHO病理分级有关（P<0.0001），与胶质瘤MGMT启动子甲基化无明显相关性（P>0.05）。Kaplan-Meier生存曲线分析显示，与HJURP高表达组相比，HJURP低表达组显示出显著的生存优势（P<0.0001）。GO、KEGG及GSVA分析显示HJURP参与脑胶质瘤细胞的有丝分裂调控、细胞周期、染色体分离等。结论 HJURP在人脑胶质瘤中异常高表达，并与不良预后相关。这提示HJURP可作为人脑胶质瘤的生物标志物。
Abstract:
Objective To explore the expression of Holliday Junction Recognition Protein (HJURP) in human glioma and its association with clinical, pathological characteristics, and prognosis of patients. Methods The mRNAseq-325 dataset containing RNA-seq data and clinical information of 325 glioma cases was retrieved from the Chinese Glioma Genome Atlas (CGGA) database by computer. The dataset of 693 glioma cases in mRNAseq-693 was utilized for validation. The relationship between the expression of HJURP and the clinical and pathological characteristics of glioma was analyzed using R language software. Kaplan-Meier survival analysis was employed to assess the influence of HJURP expression on the survival of human glioma. Results The expression level of HJURP in glioma was significantly upregulated (P<0.05); its expression level was correlated with the IDH genotype of glioma, 1p19q co-deletion status, and WHO pathological grade (P<0.0001), but not significantly related to MGMT promoter methylation (P>0.05). Kaplan-Meier survival curve analysis demonstrated that the HJURP low-expression group exhibited a significant survival advantage compared to the HJURP high-expression group (P<0.0001). GO, KEGG, and GSVA analyses revealed that HJURP was involved in the regulation of mitosis, cell cycle, and chromosome segregation in glioma cells. Conclusion HJURP is aberrantly highly expressed in human glioma and is associated with an unfavorable prognosis. This indicates that HJURP can serve as a biomarker for human glioma.

参考文献/References:

[1] VAN HOOREN L, VACCARO A, RAMACHANDRAN M, et al. Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma [J]. Nat Commun, 2021, 12(1): 4127.
[2] SZOPA W, BURLEY T, KRAMER-MAREK G, et al. Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives [J]. Biomed Res Int, 2017, 2017: 1-13.
[3] CHENG Q, TANG A, WANG Z, et al. CALD1 modulates gliomas progression via facilitating tumor angiogenesis [J]. Cancers, 2021, 13 (11): 2705.
[4] SHI J, ZHANG Y, YAO B, et al. Role of exosomes in the progression, diagnosis, and treatment of gliomas [J]. Med Sci Monit, 2020, 26: e924023.
[5] BAGLEY SJ, DESAI AS, LINETTE GP, et al. CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges [J]. Neuro-Oncol, 2018, 20(11): 1429-1438.
[6] WANG S, WEI W, YUAN Y, et al. Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells [J]. J Transl Med, 2023, 21(1): 493.
[7] TACHIWANA H, MOLLER S, BLAMER J, et al. HJURP involvement in de novo CenH3CENP-A and CENP-C recruitment [J]. Cell Rep, 2015, 11(1): 22-32.
[8] KATO T, SATO N, HAYAMA S, et al. Activation of holliday junction-recognizing protein involved in the chromosomal stability and immortality of cancer cells [J]. Cancer Res, 2007, 67(18): 8544-8553.
[9] CHEN Y, LIANG Y, YANG J, et al. Upregulation of holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer [J]. Oncol Lett, 2019 ,18 (6): 6697-6703.
[10] CAO R, WANG G, QIAN K, et al. Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop [J]. J Cancer , 2017, 8(12): 2282-2295.
[11] WEI Y, OUYANG GL, YAO WX, et al. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling [J]. Eur Rev Med Pharmacol Sci, 2019, 23(9): 3847-3856.
[12] ZHAO Z, ZHANG KN, WANG Q, et al. Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients [J]. Genomics Proteomics Bioinformatics, 2021, 19(1): 1-12.
[13] ZHAO Z, MENG F, WANG W, et al. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas [J]. Sci Data, 2017, 4(1): 170024.
[14] BAO ZS, CHEN HM, YANG MY, et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas [J]. Genome Res, 2014, 24(11): 1765-1773.
[15] ZHANG K, LIU X, LI G, et al. Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA [J]. Cancer Biol Med, 2022, 19(10): 1460-1476.
[16] WANG Y, QIAN T, YOU G, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping [J]. Neuro-Oncol, 2015, 17(2): 282-288.
[17] LIU X, LI Y, QIAN Z, et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas [J]. Neuroimage Clin, 2018, 20: 1070-1077.
[18] BLACK BE, BASSETT EA. The histone variant CENP-A and centromere specification [J]. Curr Opin Cell Biol, 2008, 20(1): 91-100.
[19] DUNLEAVY EM, ROCHE D, TAGAMI H, et al. HJURP is a cellcycle-dependent maintenance and deposition factor of CENP-A at centromeres [J]. Cell, 2009, 137(3): 485-497.
[20] TAN J, PEERAPHONG L, RUCHAWAPOL C, et al. Emerging role of HJURP as a therapeutic target in cancers [J]. Acta Materia Medica, 2024, 77: 103392.
[21] VALENTE V, SERAFIM RB, DEOLIVEIRA LC, et al. Modulation of HJURP (holliday junction-recognizing protein) levels is correlated with glioblastoma cells survival [J]. PLoS One, 2013, 8(4): e62200.
[22] SERAFIM RB, CARDOSO C, DICRISTOFARO LFM, et al. HJURP knockdown disrupts clonogenic capacity and increases radiationinduced cell death of glioblastoma cells [J]. Cancer Gene Ther, 2020, 27(5): 319-329.
[23] GRITSCH S, BATCHELOR TT, GONZALEZCASTRO LN. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system [J]. Cancer, 2022, 128(1): 47-58.
[24] LI L, LI X, MENG Q, et al. Increased expression of holliday junction-recognizing protein (HJURP) as an independent prognostic biomarker in advanced-stage serous ovarian carcinoma [J]. Med Sci Monit, 2018, 24: 3050-3055.
[25] DE TAYRAC M, SAIKALI S, AUBRY M, et al. Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas [J]. PLoS One, 2013, 8(9): e73332.

相似文献/References:

[1]付　锴　江普查　宫　睿　王　伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
　FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(12):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳　琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫　珊　徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
　YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(12):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮　夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
　LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(12):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民　褚会松　田　甜　王昆鹏　杨国军　杨立军　王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
　HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(12):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述　王　辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰　姚庆和　李晓辉　龙宇波　陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
　GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(12):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘　靖　吴立权　黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
　LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(12):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘　炎　杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明　胡新华　刘　永　陈　玖　刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]

备注/Memo

备注/Memo:
（2023-11-29收稿，2024-07-24修回）
基金项目：河北省自然科学基金（H2022206078）；河北省卫生健康委科研基金（20230047）
更新日期/Last Update: 2024-12-30